FOXO Technologies Inc., a Delaware corporation, has announced corporate actions taken by its Board of Directors and the Majority Shareholder, Rennova Health, Inc. These actions have been formalized through a written consent delivered on September 10, 2025. The specific details of these corporate actions have not been publicly disclosed. The full filing can be accessed through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FOXO Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-014210), on September 19, 2025, and is solely responsible for the information contained therein.
Comments